# Optimizing Prostate Biopsy Schemes in Men With Multiple mpMRI Visible Lesions

> **NCT06841211** · NA · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Targeted and perilesional biopsy (TPLBx)
- **PROCEDURE:** Combined targeted and systematic biopsy (CTSBx)

## Key facts

- **NCT ID:** NCT06841211
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-04-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06841211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06841211, "Optimizing Prostate Biopsy Schemes in Men With Multiple mpMRI Visible Lesions". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06841211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*